SYNTHESIS AND CHARACTERIZATION OF NEW N-TERMINAL BCHAIN MODIFIED HUMAN INSULIN ANALOGUES
Author(s) -
Jewad K. Shneine
Publication year - 2010
Publication title -
journal of al-nahrain university-science
Language(s) - English
Resource type - Journals
eISSN - 2519-0881
pISSN - 1814-5922
DOI - 10.22401/jnus.13.4.03
Subject(s) - edman degradation , size exclusion chromatography , chemistry , threonine , insulin , asparagine , amino acid , dipeptide , chromatography , high performance liquid chromatography , human insulin , aspartic acid , biochemistry , peptide sequence , stereochemistry , biology , serine , phosphorylation , endocrinology , gene , enzyme
New human insulin analogues were synthesized by fragment condensation reactions of N A1 , N B29 Msc protected native human insulin of different B-chain lengths with the dipeptide Boc-AsnThr-OH. Edman degradation was used to obtain shortened B-chain insulin intermediates. Purification of the products was achieved using gel filtration, ion exchange chromatography and RP-MPLC chromatography. Analysis of synthesized analogues accomplished by RP-HPLC chromatography and amino acid analysis. The modified insulin analogues with the amino acids Asparagine in the first position and Threonine in the second position of the N-terminal B-chain of insulin would be expected to show an enhanced T R* transition compared with that of wild-type structure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom